Literature DB >> 14638744

Opticin binds retinal growth hormone in the embryonic vitreous.

Esmond J Sanders1, Michael A Walter, Eve Parker, Carlos Arámburo, Steve Harvey.   

Abstract

PURPOSE: Opticin is a small leucine-rich repeat proteoglycan that is abundant in several ocular tissues, including the vitreous. Like other proteoglycans, opticin may have the ability to bind and regulate the release of growth factors. Previous work has shown that isoforms of growth hormone (GH) are present in the embryonic retina, where they may act as a growth factor. The current study was conducted to investigate the possibility that opticin binds retinal GH in the vitreous of the chick embryo.
METHODS: The vitreous and retina of embryonic day-8 chicks were examined for the presence of opticin and GH, by Western immunoblot analysis, coimmunoprecipitation, and immunocytochemistry.
RESULTS: Opticin associated with GH in the embryonic vitreous to produce a 60- to 62-kDa complex. Opticin and GH were also colocalized in the retina in retinal ganglion cells.
CONCLUSIONS: The binding of retinal GH by opticin in the vitreous suggests that GH, secreted by the retinal ganglion cells, may be sequestered and concentrated in the vitreous and could act there as a paracrine differentiation factor in ocular development. During development, opticin could therefore regulate growth factor-like actions of retinal GH, both in the vitreous and the retinal ganglion cells. The physiological roles of GH in this location remain to be determined, but may include the regulation of cell proliferation and cell death.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638744     DOI: 10.1167/iovs.03-0500

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

1.  Shedding light on a new eye protein.

Authors:  J V Forrester
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

Review 2.  Extrapituitary growth hormone.

Authors:  S Harvey
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 3.  The biology of small leucine-rich proteoglycans in bone pathophysiology.

Authors:  Dragana Nikitovic; John Aggelidakis; Marian F Young; Renato V Iozzo; Nikos K Karamanos; George N Tzanakakis
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

Review 4.  Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology.

Authors:  Madalina V Nastase; Renato V Iozzo; Liliana Schaefer
Journal:  Biochim Biophys Acta       Date:  2014-02-05

5.  The vitreous glycoprotein opticin inhibits preretinal neovascularization.

Authors:  Magali M Le Goff; Hongbin Lu; Marta Ugarte; Stephen Henry; Masamine Takanosu; Richard Mayne; Paul N Bishop
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

6.  Retinal growth hormone in perinatal and adult rats.

Authors:  Steve Harvey; Marie-Laure Baudet; Esmond J Sanders
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

7.  Neoplastic transformation of ciliary body epithelium is associated with loss of opticin expression.

Authors:  David C Assheton; Eoin P Guerin; Carl M Sheridan; Paul N Bishop; Paul S Hiscott
Journal:  Br J Ophthalmol       Date:  2006-09-27       Impact factor: 4.638

8.  Small chicken growth hormone (scGH) variant in the neural retina.

Authors:  Marie-Laure Baudet; Steve Harvey
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

9.  Endogenous growth hormone in human retinal ganglion cells correlates with cell survival.

Authors:  Esmond J Sanders; Eve Parker; Steve Harvey
Journal:  Mol Vis       Date:  2009-05-04       Impact factor: 2.367

10.  Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells.

Authors:  Eva Mikaelsson; Anders Osterborg; Zahra Tahmasebi Fard; Ahmad Mahmoudi; Jafar Mahmoudian; Mahmood Jeddi-Tehrani; Mehdi Akhondi; Fazel Shokri; Paul N Bishop; Hodjattallah Rabbani; Håkan Mellstedt
Journal:  Exp Hematol Oncol       Date:  2013-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.